期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

PPARγ变异与复杂疾病 被引量：4

PPARγ Variants and Complex Diseases
下载PDF
导出
摘要 过氧化物酶体增殖激活受体γ(PPARγ)是核激素受体超家族成员。PPARγ基因主要表达于脂肪组织,促进脂肪细胞分化,调控多种脂肪细胞分泌的蛋白质因子基因的表达。它也是糖尿病治疗药物噻唑烷二酮类化合物(TZDs)作用的靶分子。PPARγ的常见多态性影响胰腺β细胞功能,导致胰岛素分泌及外周组织对胰岛素敏感性的改变。它与2型糖尿病、肥胖、心血管疾病、癌症的发病风险相关联,阐明PPARγ的作用机制对复杂疾病的诊断、预防和治疗具有重要意义。 Peroxisome proliferator-activated receptor γ is a member of the nuclear hormone receptor superfamily. Mainly expressed in adipose tissue, PPARγ promotes the differentiation of adipocytes and modulates the expression of many genes involved in the synthesis of adipocytokines in the adipose tissue. It is also the target molecule of the thiazolidinediones. Polymorphisms of the PPARy gene may influence pancreatic β-cell function and result in changes in insulin secretion and insulin sensitivity of the peripheral tissues. They are also associated with risks of type 2 diabetes, obesity, cardiovascular diseases and cancer. Elucidation of its mechanism could be of major importance to the diagno- sis, prevention and treatment of complex diseases.
作者 姬森林 黄青阳
机构地区 华中师范大学生命科学学院
出处 《遗传》 CAS CSCD 北大核心 2006年第8期993-1001,共9页 Hereditas（Beijing)
基金 国家自然科学基金(编号:30340068) 教育部留学回国人员科研启动基金资助~~
关键词 过氧化物酶体增殖激活受体Γ 2型糖尿病 Pro12A1a多态性 peroxisome proliferator-activated receptorγ type 2 diabetes Pro12A1a polymorphism
分类号 R363 [医药卫生—病理学]
  • 相关文献

参考文献49

  • 1Issemen I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature,1990,347(6294) :645-650.
  • 2Lee S, Pineau T, Lee E J, Owens J W, Kroetz D L, Feernandez-Salguero P M, Westphal H, Gonzalez F J. Targeted disruption of the isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol, 1995, 15 (6) :3012-3022.
  • 3Werman A, Hollenberg A, Solanes G, Bjorbaek C, VidaI-Puig A J, Flier J S. Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor γ(PPARγ).differential activity of PPARγ1and -2 isoforms and influence of insulin. J Biol Chem, 1997,272(32) :20230 -20235.
  • 4VidaI-Puig A J, Considine R V, Jimenez-Linan M, Werman A,Dories W J, taro J F, Flier J S. Peroxisome proliferator-activated receptor gene expression in human tissue: Effects of obesity,weight loss and regulation by insulin and glucocorticoid. J Clin Invest, 1997,99(10) :2416-2422.
  • 5Yen C J, Beamer B A, Negri C, Silver K, Brown K A, Yarnall D P, Burns D K, Roth J, Shuldiner A R. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun, 1997,241(2):270-274.
  • 6赵艳红,丛祥凤,陈曦.PPARγ2基因C1431T多态与肥胖的关联研究[J].中国分子心脏病学杂志,2003,3(3):140-143. 被引量：3
  • 7Mori H, Ikegami H, Kawaguchi Y , Seino S, Yokoi N, TakedaJ, Inoue I, Seino Y, Yasuda K, Hanafusa T, Yamagata K,Awata T, Kadowaki T, Hara K, Yamada N, Gotoda T, Iwasaki N, Iwamoto Y, Sanke T, Nanjo K, Oka Y, Matsutani A, Maeda E, Kasuga M. The Pro12→Ala substitution in PPARγis associated with resistance to development of diabetes in the general populations:possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes, 2001,50(4):891-894.
  • 8Meirhaeghe A, Amouyel P. Impact of genetic variation of PPARγ.Mol Genet Metab, 2004, 83( 1 -2) :93- 102.
  • 9Deeb S S, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L,Kuusisto J, Laakso M, Fujimoto W, Auwerx J. A Pro12Ala sub-stitution in PPARγ2 is associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet, 1998,20(3) :284-287.
  • 10Altshuler D, Hirschhorn J N, Klannemark M, Lindgren C M, Vohl M C, Nemesh J, Lane C D, Schaffner S F, Bolk A, Brewer C,Tuomi T, Gaudet D, Hudson T T, Daly M, Groop L, Lander E S. The common PPARγPro12Ala polymorphisms is associated with decreased risk of type 2 diabetes. Nat Genet, 2000,26(1):76-80.

二级参考文献71

  • 1[1]Werman A, Hollenberg A, Solanes G, Bjorbaek C, Vidal-Puig A J, Flier J S. Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor γ (PPARγ). Differential activity of PPARγ1 and -2 isoforms and influence of insulin [J]. J Biol Chem, 1997, 272:20230 ～ 20235.
  • 2[2]Vidal-Puig A J,Considine R V,Jimenez-Linan M,Werman A, Dories W J ,Caro J F,Flier J S. Peroxisome proliferator-activa ted receptor gene expression in human tissue. Effects of obesi ty,weight loss and regulation by insulin and glucocorticoid [J]. J Clin Invest, 1997,99:2416～2422.
  • 3[3]Wu Z,Bucher N L R,Farmer S R. Induction of peroxisome proliferator-activated receptor γduring the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPβ, C/EBPδ, and glucocorticoids[J]. Mol Cell Biol, 1996,16: 4128～4136.
  • 4[4]Rieusser J,Andreelli D,Auboeuf D,Roques M,Vallier P,Riou J P, Auwerx J, Laville M, Vidal H. Insulin acutely regulates the expression of the peroxisome proliferator-activated recep tor γ in human adipocytes[J]. Diobetes, 1999,48: 699～ 705.
  • 5[5]Auwerx J,Staels B. Leptin[J]. Lancet,1998,351:737～742.
  • 6[6]Hollenberg A N,Susulic V S, Madura J P, Zhang B, Moller D E,Tontonoz P, Sarraf P, Spiegelman B M, Lowell B B. Func tional antagonism between CCAAT/enhancer binding protein α and peroxisome proliferator-activated receptor γ on the leptin promoter[J]. J Biol Chem, 1997,272: 5283～ 5290.
  • 7[7]Hill M,Young M,McCurdy C,Gimble J. Decreased expression of murine PPARγ in adipose tissue during endotoxinemia[J]. Endocrinology, 1997,138: 3073～3076.
  • 8[8]Ron D, Brasier A R,McGehee R E Jr, Habener J F. Tumor necrosis factor-induced reversed of adipocyte phenotype of 3T3-L1 cells is preceded by a loss of nuclear CCAAT/enhan cer binding protein(C/EBP) [J]. J Clin Invest, 1992,89: 223 ～ 233.
  • 9[9]Hofmann C,Lorenz K,Braithwaite S S. Colca J R,Palazuk B J, Hotamisligil G S,Spiegelman B M. Altered gene expression for tumor necrosis factor-α and its receptor during drug and dieta ry modulation of insulin resistance[J]. Endocrinology, 1994, 134:264～270.
  • 10[10]Yen C J,Beamer B A,Negri C,Silver K,Brown K A,Yarnall D P,Burns D K, Roth J, Shuldiner A R. Molecular scanning of the human peroxisome proliferator-activated receptor γ (PPARγ) gene in diabetic Caucasians: identification of a Pro12Ala PPARγ2 missense mutation[J]. Biochem Biophys Res Commun,1997,241 :270～274.

共引文献60

同被引文献51

引证文献4

二级引证文献11

遗传
2006年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部